INTRODUCTION
Obesity is a major contributor to numerous metabolic diseases including type 2 diabetes, hypertension, and atherosclerosis. Adipose tissue plays an essential role in regulating the whole-body energy balance. White adipose tissue (WAT) stores excess energy as lipids, whereas brown adipose tissue (BAT) expends energy as heat. The thermogenic properties of BAT are dependent on high oxidative capacity and mitochondrial density and high levels of uncoupling protein 1 (UCP1). Classical brown adipocytes are mainly located around interscapular BAT, whereas beige adipocytes, inducible brown-fat-like cells, sporadically reside in subcutaneous WAT depots (Bartelt and Heeren, 2014) . The emergence of beige adipocytes in WAT is induced by environmental stimuli, including cold exposure, exercise, long-term peroxisome proliferator-activated receptor g (PPARg) activation, and b-adrenergic receptor stimulation (Harms and Seale, 2013) . The browning of WAT can prevent diet-induced obesity and improve metabolism (Kajimura and Saito, 2014) . Notably, recent studies also suggest that these beige adipocytes can significantly contribute to the energy balance in humans (Sidossis and Kajimura, 2015) .
Obesity-associated macrophage infiltration in adipose tissues is coupled with the recruitment of proinflammatory M1 macrophages, leading to increased expression of proinflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-a) (McLaughlin et al., 2017) . These proinflammatory cytokines induce an inflammatory phenotype in adipocytes and prevent adipogenesis of 3T3-L1 cells (Gustafson and Smith, 2006) . Elevated circulating lipopolysaccharide (LPS) levels in obesity also trigger inflammation in macrophages and preadipocytes of adipose tissues, and LPS treatment inhibits differentiation of adipocyte precursors in vitro (Zhao and Chen, 2015) . In addition to LPS, interferon-a (IFN-a), a key stimulator of the innate immune response, inhibits adipogenesis of 3T3-L1 cells (Lee et al., 2016) . Thus, accumulating evidence indicates that activation of innate immune responses negatively regulates adipocyte differentiation. However, the molecular players that repress innate immune responses in adipocytes remain elusive.
Activating transcription factor 7 (ATF7) belongs to the vertebrate ATF2 subfamily of transcription factors, which has three members: ATF2 (originally named CRE-BP1) (Maekawa et al., 1989; Hai et al., 1989) , CRE-BPa (Nomura et al., 1993) , and ATF7 (originally named ATFa) (Gaire et al., 1990) . ATF2 proteins reportedly contribute to the regulation of adipocyte differentiation and function. Atf2 +/À Cre-bpa +/À double-heterozygous mice exhibit reduced WAT mass, and bone morphogenetic protein 2 can induce the p38-dependent phosphorylation of ATF2, which binds to the promoter region of Pparg2 to stimulate adipocyte differentiation (Maekawa et al., 2010a) . The p38-dependent activation of ATF2 is also required for the induction of thermogenic genes, including Ucp1 (Cao et al., 2004) , Pgc1a (Bordicchia et al., 2012; Yao et al., 2017) , and Zfp516 (Dempersmier et al., 2015) , in BAT in response to various stimuli. Although ATF7 shares a relatively high amino acid sequence identity with ATF2, it represses rather than activating, gene expression in the absence of stress (Seong et al., 2012) . ATF7 recruits histone methyltransferases to silence the transcription of target genes. Histone H3K9 trimethyltransferase ESET/SETDB1 is recruited by ATF7 to promote the formation of heterochromatin-like structure on the regulatory region of the Htr5b gene, which encodes serotonin receptor 5b, in the dorsal raphe nuclei of the brain (Maekawa et al., 2010b) . Social isolation stress induces the phosphorylation of ATF7 via p38 and leads to the release of ATF7 and ESET/SETDB1 from target genes, resulting in transcriptional activation. ATF7 represses a group of innate immunity-related genes in macrophages by associating with H3K9 dimethyltransferase G9a. Pathogen-infection-induced phosphorylation of ATF7 stimulates the release of ATF7-G9a from target genes, accompanied by a decrease in repressive histone H3K9me2 levels, leading to elevated gene expression . In mouse embryonic fibroblast cells, ATF7 regulates H3K9me3 levels on pericentromeric heterochromatin and telomeres by interacting with Suv39h1 (Maekawa et al., 2018) .
Our previous study found that deletion of Atf7 reduced adipose tissue mass and increased energy expenditure in mice fed a high-fat diet (Liu et al., 2016) , implying that ATF7 may participate in the regulation of energy balance. In the present work, we have more precisely analyzed the role of ATF7 in adipocyte differentiation and showed that ATF7 facilitates adipogenesis by repressing innate immune responses, whereas it suppresses beige adipocyte biogenesis via dimethylation of H3K9 on thermogenic gene enhancers. Thus ATF7 has a dual role for the regulation of white adipocyte differentiation and beige fat biogenesis in inguinal white adipose tissue (iWAT).
RESULTS

ATF7 Deficiency Impairs Adipocyte Differentiation
Atf7-deficient (Atf7 À/À ) mice exhibited reduced adipose tissue mass, suggesting that ATF7 may contribute to adipocyte differentiation (Liu et al., 2016) . To investigate the function of ATF7 in the regulation of adipocytes, we examined whether ATF7 was expressed in fat tissues. ATF7 was detected in BAT, iWAT, and epididymal WAT ( Figure 1A) . The stroma-vascular fraction (SVF) of adipose tissues provides a rich reservoir of adipocyte precursors. We measured the expression levels of Atf7, Wnt10b, and Prdm16 genes in isolated mature adipocytes and the SVF from BAT and iWAT. Wnt10b expression decreases during adipocyte differentiation (Cawthorn et al., 2012) , and Prdm16 is mainly expressed in mature adipocytes (Seale et al., 2007) . In line with previous reports, we also observed that Wnt10b was mainly expressed in the SVF, whereas Prdm16 exhibited higher expression levels in adipocytes than in the SVF (Figures S1A and S1B). However, there was no difference in Atf7 gene expression in adipocytes from BAT and iWAT. ATF7 was also expressed at comparable levels in the SVF and mature adipocytes ( Figure 1B ). To explore the expression of Atf7 during adipocyte differentiation, we used inguinal primary preadipocytes and measured gene expression by quantitative PCR (qPCR). The results indicated that Atf7 expression was reduced by 40% (day 2) after cells were cultured in induction medium, and expression then increased to day 0 levels, whereas expression of the adipogenesis marker Fabp4 gradually increased during adipocyte differentiation ( Figure 1C ).
To determine the function of ATF7 in adipocyte differentiation, we used primary inguinal preadipocytes isolated from wild-type (WT) and Atf7 À/À mice to examine whether loss of ATF7 affects adipogenesis. ATF7 ablation reduced the number of oil red O-stained mature adipocytes ( Figure 1D ), and the expression level of adipogenic markers Pparg, C/ebpa, and Fabp4 ( Figures 1E and 1G ). By contrast, C/ebpb expression levels were not affected by ATF7 deficiency ( Figure 1E ). When cells were induced to undergo adipocyte differentiation in the presence of the PPARg agonist rosiglitazone (Rosi), which promotes adipogenesis and activates brown-selective genes (Schoonjans et al., 1996) , Atf7 expression exhibited similar changes to those observed in the absence of Rosi, indicating that this agent did not affect Atf7 expression ( Figures S2A and S2B) . Notably, the presence of Rosi rescued ATF7-deficiency-induced impairment of adipogenesis. Oil red O staining revealed no difference in lipid accumulation between WT and Atf7 À/À cells cultured with Rosi ( Figure 1F ). Rosi dramatically up-regulated Fabp4 expression in both WT and ATF7 knockout (KO) cells, and importantly, Fabp4 expression in ATF7 KO cells was comparable to that in WT cells in the presence of Rosi ( Figure 1G ). Compared with WT cells, the common adipogenic markers Pparg, C/ebpa, and C/ebpb also exhibited similar expression levels in Atf7 À/À cells when treated with Rosi ( Figure S2C ). These findings indicate that ATF7 negatively regulates adipogenesis, directly or indirectly, by repressing Pparg expression.
ATF7 Represses Innate Immune-Related Genes in Adipocytes
To investigate the mechanism by which ATF7 suppresses adipogenesis, we performed RNA sequencing (RNA-seq) on adipocytes (D7) derived from inguinal preadipocytes in the presence and absence of Rosi. In the absence of Rosi, 673 genes were up-regulated and 237 genes were down-regulated by the loss of ATF7, and Gene Ontology analysis revealed that up-regulated genes were related to immune responses ( Figure 2A ). The most enriched pathways associated with these up-regulated genes included innate immune responses, defense responses to viruses, and cellular responses to IFN-b, whereas the down-regulated genes were mainly related to lipid metabolism and storage ( Figure S3A ). We also identified 200 genes that were up-regulated and 174 genes that were down-regulated in Atf7 À/À cells compared with WT cells in Figure 1 . Loss of ATF7 Impairs Adipogenesis (A) ATF7 protein expression levels in BAT, iWAT, and epididymal WAT measured by immunoblotting. (B) Atf7 mRNA expression levels in mature adipocytes and stromal vascular cells isolated from BAT and iWAT (n = 3, three biological replicates). Data are presented as mean G SD. Statistical analysis was performed using two-tailed unpaired Student's t tests. (C) Atf7 (left) and Fabp4 (right) gene expression during the differentiation time course of primary iWAT preadipocytes (n = 3, three biological replicates). (D) Oil red O staining of wild-type (WT) and Atf7 À/À primary iWAT preadipocytes at 7 days after induction of differentiation in the absence of rosiglitazone (Rosi). (E) Expression of the common adipogenic genes Pparg, C/ebpa, and C/ebpb, detected by real-time PCR during the differentiation time course of WT and Atf7 À/À primary iWAT preadipocytes (n = 3, three biological replicates). (F) Oil red O staining of WT and Atf7 À/À primary iWAT preadipocytes at 7 days after induction of differentiation in the presence of Rosi. (G) Fabp4 gene expression levels in differentiated WT and Atf7 À/À primary iWAT preadipocytes in the presence or absence of Rosi. Data are presented as means G SD. Statistical analysis was performed using two-way ANOVA followed by Holm-Sidak multiple comparison tests. *p < 0.05, **p < 0.01, ***p < 0.001 versus WT (without Rosi treatment). See also Figures S1 and S2. the presence of Rosi, and down-regulated genes were related to positive regulation of angiogenesis, negative regulation of insulin secretion, and cellular response to IL-1 and TNF-a ( Figure S3B ). Interestingly, pathway analysis for up-regulated genes gave similar results to those obtained from adipocytes cultured without Rosi ( Figure 2B ). These up-regulated genes were also mainly associated with immune response pathways, implying that ATF7 may inhibit immune-related gene expression in adipocytes.
To clarify the factors potentially modulating these up-regulated genes in Atf7 À/À adipocytes, we performed motif analysis of promoter regions and found that interferon-stimulated response element (ISRE) was the most enriched motif in genes up-regulated in Atf7 À/À cells in both the presence and absence of Rosi. Without Rosi, 6.53% of the 673 gene promotors contain an ISRE, and in the presence of Rosi, this ratio increases to 22.22% ( Figure 2C ). Furthermore, 57 genes overlap between the two up-regulated gene sets, including many interferon-stimulated genes (ISGs) such as Irf7, Ifit1, Ifit3, Rsad2, and Oasl2 (Figures 2D and 2E) . In accordance with the RNA-seq data, the results of qPCR demonstrated that ISGs were more highly expressed in Atf7 À/À adipocytes (D7), and they were also increased in Atf7 À/À preadipocytes compared with WT controls ( Figure 2F ). To further validate the role of ATF7 in the regulation of ISG expression, we overexpressed ATF7 in the C3H10T1/2 murine mesenchymal stem cell line ( Figure S4A ). Expression of ISGs was stimulated by treatment with LPS (0.5 mg/mL) for 12 h. However, overexpression of ATF7 significantly repressed ISG expression in the absence and presence of LPS ( Figure S4B ). Taken together, these results suggest that ATF7 suppresses the induction of ISGs, and loss of ATF7 stimulates ISG expression during adipocyte differentiation.
In contrast to in vitro data, the results of qPCR and immunofluorescence staining demonstrated that loss of ATF7 did not affect the inflammation level of iWAT ( Figures S5A and S5B ). Interestingly, we found that loss of ATF7 led to a dramatic reduction in the Retn gene expression in adipocytes ( Figure S5C ). This finding was consistent with the lower circulating resistin observed in the Atf7 À/À mice (Liu et al., 2016) . Given the proinflammatory properties of resistin in adipose tissue (Qatanani et al., 2009) , the reduction of resistin may counter the adipose tissue inflammation induced by the activation of innate immune response in Atf7 À/À adipocytes. These results suggest that ISGs are up-regulated in Atf7 À/À adipocytes, but it does not cause the inflammation at the tissue level because of negative feedback regulation by resistin.
Activation of ISGs Impairs Adipogenesis
To examine the effect of the induction of ISGs on adipogenesis, we treated preadipocytes with LPS (0.5 mg/ mL) for 24 h and found that LPS treatment dramatically stimulated the expression of ISGs ( Figure S6A ). By contrast, Pparg expression levels in LPS-treated cells were reduced by approximately half compared with those in phosphate-buffered saline (PBS)-treated control cells ( Figure S6B ), implying that LPS treatment may impair adipogenesis by repressing Pparg expression. A previous study demonstrated that LPS treatment for 24 h before the induction of adipocyte differentiation results in the profound impairment of adipogenesis (Zhao and Chen, 2015) . In line with these previous observations, we also found that adipocyte differentiation was severely blunted by LPS exposure for 24 h before addition of induction medium. In the absence of Rosi, LPS treatment led to decreased lipid accumulation and lower expression levels of adipogenic markers ( Figures S6C and S6D) . Interestingly, the presence of Rosi during differentiation clearly rescued the impairment of adipogenesis induced by LPS treatment. The results of oil red O staining demonstrated that Rosi mitigates the effect of LPS treatment on lipid accumulation ( Figure S6C ). Moreover, there was no difference in expression levels of Pparg between LPS-and PBS-treated cells in the presence of Rosi, although Fabp4 and C/ebpa expression remained slightly reduced following LPS treatment ( Figure S6D ). IFN-a can stimulate the expression of ISGs and inhibit adipogenesis in 3T3-L1 cells (Lee et al., 2016) . However, the inhibitory effect of IFN-a on adipogenesis in brown adipocyte precursors was not observed (Kissig et al., 2017) . To examine the effect of IFN-a on adipogenesis in iWAT preadipocytes, we measured the expression of ISGs in preadipocytes following exposure to IFN-a (500 U/mL) for 24 h and found that expression levels of ISGs Stat1 and Stat2 were significantly elevated by IFN-a ( Figure 3A ). By contrast, Pparg expression levels in IFN-a-treated cells were reduced by 80% compared with those in control cells (Figure 3B) . Exposure to IFN-a during adipocyte differentiation severely inhibited lipid accumulation and expression of adipogenic markers ( Figure 3C and 3D). Taken together, these results indicate that induction of ISGs by LPS and IFN-a is accompanied by a reduction in Pparg expression, leading to inhibition of adipogenesis.
ATF7 Recruits G9a to Repress Stat1 Expression in Preadipocytes
Given that ATF7 associates with histone dimethyltransferase G9a to suppress the expression of innate immunerelated genes in macrophages , we speculated that inhibition of ISG expression in adipocytes by ATF7 may occur in the same manner. To test this hypothesis, we first compared genes up-regulated by loss of ATF7 in macrophages and adipocytes. Among the top 250 genes up-regulated in Atf7 À/À macrophages, 58 also exhibited higher expression levels in Atf7 À/À adipocytes than in WT controls ( Figure S7A ). Pathway analysis of these 58 overlapping genes revealed their association with innate immune responses ( Figure S7B ). To examine whether ATF7 inhibits the expression of ISGs via recruitment of G9a, we performed a co-immunoprecipitation (coIP) experiment in preadipocytes using anti-ATF7 antibody. The results demonstrated that ATF7 does indeed form a complex with endogenous G9a in preadipocytes ( Figure 4A ). STAT1 functions as a master regulator of the induction of ISGs by binding to ISREs. In macrophages, ATF7 directly binds the promoter region of Stat1 to repress its expression . Thus we speculated that Stat1 may also be a target gene of ATF7 in preadipocytes. Chromatin immunoprecipitation-qPCR results confirmed that ATF7 binds directly to the promoter of the Stat1 gene in preadipocytes ( Figure 4B ). Importantly, the loss of ATF7 led to lower H3K9me2 levels at the promoter region of the Stat1 gene, and increased expression of Stat1 in Atf7 À/À preadipocytes ( Figures 4C and 4D) . These findings imply that ATF7 may recruit G9a to the promoter region of Stat1 and repress its expression through dimethylation of H3K9 in preadipocytes. Elevated STAT1 induced by loss of ATF7 in turn stimulates the expression of ISGs and inhibits adipogenesis.
Loss of ATF7 Promotes the Thermogenic Programming and Browning of iWAT
The PPARg agonist Rosi induces thermogenic gene programming of beige and brown adipocytes (Ohno et al., 2012) . RNA-seq data showed that the majority of BAT-selective genes, including Ucp1, Cidea, Ppara, and Otop1, were evidently stimulated by Rosi treatment in both WT and Atf7 À/À cells ( Figure 5A ). Interestingly, Ucp1 exhibited higher expression in Atf7 À/À cells than in WT cells in the presence of Rosi ( Figure 5B ). Other thermogenic genes, such as Cidea, Cox8b, and Pgc1a, were also increased by the loss of ATF7, whereas Prdm16 expression was not significantly different between WT and Atf7 À/À cells ( Figure 5C ). The acute stimulation of thermogenic genes in response to the activation of b-adrenergic receptors is one of the main functional characteristics of beige/brown adipocytes. To examine whether ATF7 is essential for this, differentiated WT and Atf7 À/À cells were treated with isoproterenol (Iso), a synthetic pan b-adrenergic receptor agonist. Ucp1 expression levels were significantly increased in both WT and Atf7 À/À cells after Iso exposure for 4 h ( Figure 5D ). Of note, the increase in Ucp1 expression stimulated by Iso was comparable in WT and Atf7 À/À cells ($4-fold), implying that ATF7 may be dispensable for activation of beige cells via b-adrenergic receptors. These findings indicate that loss of ATF7 promotes thermogenic programming in a cell-autonomous manner.
To determine whether ATF7 contributes to thermogenic programming of beige or brown adipocyte in vivo, we examined UCP1 protein levels in BAT and iWAT in WT and Atf7 À/À mice. We found that loss of ATF7 did not affect UCP1 abundance in BAT, but UCP1 expression was increased in iWAT in Atf7 À/À mice compared with WT controls ( Figure 6A ). To assess the morphology of adipocytes in iWAT, we performed hematoxylin and eosin staining of iWAT sections, and more multilocular adipocytes were observed in iWAT from Atf7 À/À mice than from WT controls ( Figure 6B ). Importantly, immunohistochemical staining showed that the number of UCP1-positive cells was markedly increased by ablation of ATF7, consistent with evaluated UCP1 protein levels in iWAT from ATF7 KO cells ( Figures 6A and 6B ). To explore gene expression profiles in iWAT induced by the loss of ATF7, we performed microarray analysis using RNA isolated from iWAT in Atf7 À/À and WT control cells. The results revealed that 115 genes, including Ucp1, Cidea, Pgc1a, and Ppara, were up-regulated in Atf7 À/À iWAT compared with control tissue ( Figure 6C ). Pathway analysis revealed that these genes are associated with adaptive thermogenesis and fatty acid metabolism ( Figure 6D ). Subsequent qPCR results further confirmed that several brown-fat-selective genes including Ucp1, Cidea, Ppara, and Ntrk3, and mitochondrial genes including Cox7a1 and Cox8b, were increased in iWAT following loss of ATF7, whereas there was no change in the expression of common adipocyte genes including C/ebpa, Fabp4, and Pparg ( Figure 6E ). However, except for Ntrk3, expression of brown-fat-selective genes did not differ between WT and Atf7 À/À BAT. In addition, there were no changes in the expression of mitochondrial and common adipocyte genes in Atf7 À/À BAT compared with WT controls ( Figure S8A ). In line with the results of thermogenic gene expression in BAT, there is no significant difference in the tolerance to acute cold exposure between Atf7 À/À and WT littermates ( Figure S8B ). Taken together, the in vivo and Figure 5 . Loss of ATF7 Promotes Thermogenic Gene Programming (A) Heatmap showing the expression levels of BAT-selective genes in WT and Atf7 À/À cells in the presence or absence of rosiglitazone (Rosi; n = 2, two biological replicates). (B) Ucp1 gene expression levels in WT and Atf7 À/À differentiated primary iWAT preadipocytes in the presence or absence of Rosi (n = 3, three biological replicates). Data are presented as means G SD. Statistical analysis was performed using two-way ANOVA followed by Holm-Sidak multiple comparison tests. **p < 0.01, ***p < 0.001. (C) Thermogenic gene expression levels in differentiated WT and Atf7 À/À primary iWAT preadipocytes treated with Rosi (n = 3, three biological replicates). Data are presented as means G SD. Statistical analysis was performed using two-tailed unpaired Student's t tests. *p < 0.05. (D) Relative mRNA levels of Ucp1 in differentiated WT and Atf7 À/À primary iWAT preadipocytes before and after treatment with 2 mM isoproterenol (Iso) for 4 h (n = 3, three biological replicates). Data are presented as means G SD. Statistical analysis was performed using two-way ANOVA followed by Holm-Sidak multiple comparison tests. *p < 0.05, ***p < 0.001 versus WT (no Iso treatment).
in vitro results suggest that ATF7 contributes to the regulation of beige adipocyte biogenesis by suppressing thermogenic gene programming.
Overexpression of ATF7 Inhibits Thermogenic Gene Programming
To further explore the molecular mechanism of ATF7 functions in beige cell biogenesis, we used C3H10T1/ 2 multipotent mesenchymal cells, which have the capacity to undergo brown or beige adipogenic differentiation when treated with an adipogenic cocktail. The results revealed no obvious change in ATF7 protein abundance during differentiation, but phosphorylation of ATF7 was induced during the later stages of Figure 6 . ATF7 Ablation Promotes Browning of iWAT (A) Relative UCP1 protein levels in BAT and iWAT of WT and Atf7 À/À littermates (n = 2, two biological replicates). (B) Hematoxylin and eosin staining (upper) and UCP1 immunohistochemical analysis (lower) of iWAT from WT and Atf7 À/À littermates. (C) Heatmap depicting expression levels of differentially expressed genes induced by loss of ATF7 in WT and Atf7 À/À littermates (n = 3, three biological replicates). (D) Pathway analysis for up-regulated genes in Atf7 À/À iWAT. (E) Expression of brown-fat-selective genes, common adipocyte genes, and mitochondrial genes in iWAT from WT and Atf7 À/À littermates (n = 3, three biological replicates). differentiation ( Figure 7A ). To examine the role of ATF7 in differentiation, FLAG-tagged ATF7 was expressed in C3H10T1/2 cells via a lentiviral vector, and overexpression of ATF7 did not affect lipid accumulation, as shown by oil red O staining ( Figure 7B ). However, RNA-seq data indicated that expression of brown-fat-selective genes, including Ucp1, Cidea, Ppara, Kcnk3, and Otop1, was reduced following overexpression of ATF7 ( Figure 7C) . Notably, these down-regulated genes induced by ATF7 overexpression are (F) Relative mRNA levels of thermogenic genes in differentiated control and ATF7-overexpressing cells (n = 3, three biological replicates). Data are presented as means G SD. Statistical analysis was performed using two-tailed unpaired Student's t tests. **p < 0.01, ***p < 0.001. (G) Ucp1 gene expression levels before and after treatment with 2 mM isoproterenol (Iso) for 4 h in control and ATF7-overexpressing cells (n = 3, three biological replicates). Data are presented as means G SD. Statistical analysis was performed using two-way ANOVA followed by Holm-Sidak multiple comparison tests. *p <0.05, **p < 0.01 versus controls (without Iso treatment), ***p < 0.001 versus controls (with Iso treatment). related to fatty acid and lipid metabolism ( Figure 7D ), similar to the pathways associated with genes upregulated in Atf7 À/À iWAT ( Figure 6D) . We next compared genes down-regulated by ATF7 overexpression in differentiated C3H10T1/2 cells and up-regulated by ATF7 ablation in iWAT. As shown in the Venn diagram ( Figures 7E) , 22 genes including Ucp1, Cidea, Ppara, and Cox7a1 overlap between these two gene sets. The results of qPCR experiments further confirmed that ATF7 overexpression led to a reduction in the expression of brown-fat-selective genes Cidea, Elovl3, and Ppara, and mitochondrial genes Cox7a1 and Cox8b ( Figure 7F ). Although overexpression of ATF7 strongly inhibited Ucp1 expression, there was a 3-fold increase in Ucp1 expression after Iso treatment in ATF7-overexpressing cells, whereas Iso stimulation led to a 3-fold increase in Ucp1 expression in control cells ( Figure 7G ). These results further suggest that ATF7 does not participate in the acute activation of Ucp1 via b-adrenergic stimulation.
ATF7 Associates with C/EBPb and Regulates Histone Modification of Ucp1 Enhancers
To explore the molecular mechanism underlying the repressive role of ATF7 in thermogenic gene programming, we examined whether ATF7 associates with PRDM16, which is the master regulator of the thermogenic gene programming. However, coIP experiment was performed using 293T cells, and the results indicated that ATF7 interacts with C/EBPb, but not with PRDM16 ( Figure 8A) , implying that ATF7-induced suppression of thermogenic gene programming is likely not mediated by PRDM16. To further confirm whether ATF7 associated with C/EBPb in the adipocytes, coIP experiment was performed using ATF7-overexpressing C3H10T1/2 cells after differentiation in the presence of Rosi for 4 days. We found that the interaction between ATF7 and endogenous C/EBPb could be detected in the adipocytes ( Figure 8B ). Recent study demonstrated that C/EBPb binds to the enhancer regions of thermogenic genes and controls their expression in response to IL-10 treatment Rajbhandari et al., 2018) . Although overexpression of ATF7 did not affect the binding of C/EBPb to Ucp1 enhancers located 12, 5, and 2.5 kb upstream of transcription start sites, the elevated H3K9me2 levels on these regions were detected in the ATF7-overexpressing C3H10T1/2 cells after differentiation for 5 days (Figure 8C ). As these enhancer regions contain the CRE (cAMP response element) sequence, we speculated that ATF7 may bind to these regions (Rajbhandari et al., 2018) . The results of quantitative chromatin immunoprecipitation (qChIP) analysis confirmed that ATF7 directly binds to these enhancers in C3H10T1/2 cells after differentiation for 5 days ( Figure 8D ). We also investigated the effect of ATF7 deficiency on H3K9me2 levels on those enhancers, and levels on the enhancer located 5 kb upstream from the transcription start site in Atf7 À/À primary iWAT preadipocytes were lower than in WT cells after differentiation in the presence of Rosi for 7 days (Figure 8E) , indicating that ATF7 silences Ucp1 gene expression by increasing H3K9me2 levels. Thus these findings demonstrate that ATF7 associates with C/EBPb, binds enhancers of the Ucp1 gene, and represses gene expression via H3K9me2.
DISCUSSION
In this study, we found that loss of ATF7 impairs adipogenesis and induces expression of innate immunerelated genes. A previous study demonstrated that ATF7 represses innate immune gene expression in macrophages via modulation of H3K9 dimethylation levels at promoter regions . Consistent with this function in macrophages, our results demonstrated that ATF7 also functions as a repressive regulator of innate immune genes in preadipocytes. Interestingly, preadipocytes can act as macrophage-like immune cells and express the same cytokines as macrophages (Cousin et al., 1999) . Under certain conditions, preadipocytes can be converted to macrophages, further implying that they may share the same regulatory mechanisms regarding regulation of innate immune responses (Charriè re et al., 2003) . We therefore predicted that the inhibitory function of ATF7 in innate immune-related gene expression in preadipocytes is mediated by association with G9a. In line with our hypothesis, deletion of G9a led to the activation of innate immune genes in brown preadipocytes, although G9a blocked adipogenesis by suppressing Pparg expression .
Our results demonstrated that the promoter regions of up-regulated genes contain ISRE motifs that are recognized by STAT1. ATF7 directly binds to the promoter of Stat1 and represses its transcription in preadipocytes via epigenetic regulation, implying that the inhibitory effect of ATF7 on innate immune gene expression is mainly mediated by STAT1. Of note, the JAK/STAT1 signaling pathway reportedly mediates the inhibitory effect of IFN-a on adipocyte differentiation (Lee et al., 2016) . Moreover, in vitro studies suggest that STAT1 binds to the Pparg2 promoter in 3T3-L1 adipocytes and represses its transcription (Hogan and Stephens, 2001) . Thus ATF7 may facilitate adipogenesis by indirectly regulating Pparg expression via STAT1. Consistent with this possibility, we observed that the Pparg agonist rosiglitazone could rescue impaired adipogenesis in ATF7-deficient primary cells. It was previously demonstrated that LPS treatment results in the defective adipogenic potential of preadipocytes independently of nuclear factor-kB (Zhao and Chen, 2015) , and phosphorylation of ATF7 in response to LPS treatment contributes to the activation of innate immune genes . Our results showed that overexpression of ATF7 blocks LPS-induced activation of innate immune genes, further suggesting that ATF7 mediates the inhibitory effect of LPS on adipogenesis.
Adipocyte differentiation and thermogenic gene programming are controlled by distinct transcriptional regulatory mechanisms, even though several common transcriptional regulators, such as TLE3 and ZFP423, are shared by these two processes. Both TLE3 and ZFP423 stimulate adipogenesis through activation of PPARg (Villanueva et al., 2011; Gupta et al., 2010) ; TLE3 suppresses thermogenic gene programming by disrupting interactions between PRDM16 and PPARg (Villanueva et al., 2013) , whereas ZFP423 inhibits thermogenic gene programming by suppressing Ebf2 (Shao et al., 2016) . However, ATF2 acts as a positive regulator during adipogenesis and stimulates thermogenic genes (Maekawa et al., 2010a; Cao et al., 2004) . (E) H3K9me2 enrichment on enhancers of Ucp1 genes in WT and Atf7 À/À primary iWAT preadipocytes after differentiation in the presence of Rosi for 7 days (n = 3, three biological replicates). Data are presented as means G SD. Statistical analysis was performed using two-tailed unpaired Student's t tests. *p < 0.05, **p < 0.01, ***p < 0.001.
Our results reveal that, similar to TLE3 and ZFP423, ATF7 promotes adipogenesis while inhibiting adipocyte thermogenic gene programming. Interestingly, unlike ATF2, ATF7 was found to be dispensable for acute induction of Ucp1 by activation of b-adrenergic receptors. Although the browning of iWAT was observed in Atf7 À/À mice, a difference in thermogenic gene expression in BAT was not detected. These findings suggest that ATF7 mainly contributes to the regulation of beige cell biogenesis, rather than the stimuli-induced acute enhancement of Ucp1 expression.
Beige adipocyte biogenesis is regulated by a number of epigenetic regulators (Inagaki et al., 2016) , and accumulating evidence suggests that the dynamic enhancer epigenome is tightly correlated with thermogenic gene programming in adipocytes (Roh et al., 2018; Lee et al., 2017) . Notably, the amount of the repressive chromatin marker H3K9me2 on enhancers of thermogenic genes, including Ucp1 and Cidea, is reduced, whereas levels of the active histone marker H3K27ac are increased during brown or beige cell biogenesis Brunmeir et al., 2016) . Deletion of HDAC3 in adipose tissue leads to increased H3K27 acetylation of Ucp1 and Ppara enhancers, resulting in the browning of WAT (Ferrari et al., 2017) . Our results showed that ATF7 associates with C/EBPb and represses thermogenic gene programming via H3K9 dimethylation on enhancers of Ucp1. A recent study demonstrated that the recruitment of C/EBPb and ATF2 is accompanied by altered histone modification on enhancer regions, which mediates the inhibitory effect of IL-10 signaling on thermogenic gene programming (Rajbhandari et al., 2018) . C/EBPb is essential for brown and beige adipocyte development through formation of a transcriptional complex with PRDM16 (Kajimura et al., 2009) .
We identified that ATF7 as the transcriptional repressor of IFN signaling in adipocytes. Recent study shows that the activation of ISGs induced by IFN-a impairs the thermogenic gene programming and disrupts the mitochondrial structure in the brown adipocytes (Kissig et al., 2017) . Importantly, repression of the IFN signaling by blocking of JAK-STAT pathway promotes the browning of human adipocytes (Moisan et al., 2015) , highlighting the repressive role of IFN-JAK-STAT signaling in thermogenic gene expression. However, we found that loss of ATF7 promotes thermogenic gene programming, although ISGs exhibited higher level in Atf7 À/À adipocytes, suggesting that ATF7 controls the expression of thermogenic genes mainly through repressive epigenetic modification on the enhancers rather than the repression of JAK-STAT pathway in adipocytes. Enhancement of beige adipocyte biogenesis by a loss of ATF7 by regulating the dimethylation of H3K9 on thermogenic gene enhancers might be more dominant compared with suppression of the same by the JAK-STAT pathway.
Expression of thermogenic genes is closely linked to environmental factors such as low temperature. Repeated cold exposure leads to increased activity in brown and beige cells, which confers beneficial effects to metabolic homeostasis (Bartelt and Heeren, 2014) . A recent study indicates that paternal cold exposure before conception can enhance thermogenic gene expression in offspring by reprogramming the sperm epigenome (Sun et al., 2018) . Notably, dATF2, the homolog of mammalian ATF7 in Drosophila, acts as a transcriptional repressor and mediates stress-induced epigenetic inheritance (Seong et al., 2011) . Combined with our current results, these findings suggest that ATF7 may mediate epigenetic changes in sperm induced by cold exposure and contribute to enhanced brown or beige cell activity in the offspring of a father that experienced cold before conception.
Limitations of Study
Our results demonstrate that ATF7 can associate with C/EBPb in adipocytes, although ATF7 may not disrupt the interaction between Prdm16 and C/EBPb. However, at present, we cannot rule out the possibility that ATF7 blocks the association of C/EBPb with other partners, such as the SWI/SNF complex (Kowenz-Leutz and Leutz, 1999) , resulting in a reduction in C/EBPb transcriptional activity. Furthermore, whether binding of ATF7 to enhancers of Ucp1 is dependent on C/EBPb also needs further investigation.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
DATA AND SOFTWARE AVAILABILITY
The accession number of microarray data reported in this paper is GEO: GSE122374 and the accession number of RNA-seq data reported in this paper is GEO: GSE122346.
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The Transcription Factor ATF7 1, 2, 3, 4 , 5, 6, and 7.
Controls Adipocyte Differentiation and Thermogenic Gene Programming
Gene
Forward primer (5'3') Reverse primer (5'3') 
Animals
ATF7-deficient (Atf7 -/-) mice were generated as described previously (Maekawa et al., 2010) . Atf7 -/and wild-type (WT) littermates derived from Atf7 heterozygotes in a C57BL/6 background were used in this study. Experiments were conducted in accordance with the Guidelines of the Animal Care and Use Committee of the RIKEN Institute. No randomization of animals was used. The investigators were not blinded to group allocation of mice during the experiments.
Antibodies
Mouse monoclonal antibodies (1A7 and 2F10) against ATF7 were supplied by Dr. Bruno Chatton.
Antibodies recognizing Flag-tag (F3165) and HA-tag (ab9110) were purchased from Sigma and Abcam, respectively. A rabbit polyclonal phosphor-specific antibody against ATF2-Thr71/ATF7-Thr53 (#9221) was purchased from Cell Signaling. A mouse monoclonal antibody recognizing H3K9me2 (MABI0307) was purchased from MBL. Antibodies against actin (I-19, sc-1616), glyceraldehyde-3-phosphate dehydrogenase (GAPDH; FL-335, sc-25778), tubulin (B-7, sc-5286), F4/80 (3H2113, sc-71088), and C/EBPβ (C-19, sc-150) were purchased from Santa Cruz Biotechnology. A rabbit polyclonal antibody recognizing UCP1 (Ab10983) was purchased from Abcam. Antibodies against Prdm16 (AF6295) and G9a (A8620A) were purchased from R&D Systems and Perseus Proteomics, respectively.
Isolation of mature adipocyte and stromal vascular cells
Fat tissues were dissected from 68-week-old male mice and digested in digestion buffer containing 10 mM CaCl2, 2% bovine serum albumin (BSA), and 1 mg/ml collagenase (SIGMA, C0130) in phosphate-buffered saline (PBS) for 60 min at 37°C, followed by washing with DMEM/F12 medium (Life Technologies/Gibco, #10565018) containing 10% fetal bovine serum (FBS). Digested tissues were filtered with 70 μM cell strainers, and the flow-through was centrifuged at 450  g for 5 min. Stromal vascular cells were pelleted, and mature adipocytes were separated as the floating layer.
Primary cell culture and differentiation
To isolate primary iWAT preadipocytes, inguinal iWATs were isolated from 46-week-old male mice, and stromal vascular cells were isolated as described above. Cells were washed with PBS twice for 2 h each time after seeding on plates, then cultured in DMEM/F12 medium with 10% FBS until confluence. To induce cell differentiation, confluent cells were challenged for 2 days in induction medium (DMEM/F12 with 10% FBS, 5 μg/ml insulin, 1 μM dexamethasone, 0.5 mM isobutylmethylxanthine). Subsequently, cells were cultured in maintenance medium (DMEM/F12 with 10% FBS, 5 μg/ml insulin) for 5 more days, and medium was replaced every other day. Cells were incubated in the presence or absence of 1 μM rosiglitazone (Rosi) for the entire differentiation time course. To activate β-adrenergic receptor signaling, cells were treated with 2 μM isoproterenol for 4 hr. To examine the effects of innate immune responses on adipocyte differentiation, cells were incubated with 0.5 μg/ml LPS (L4391, Sigma) for 24 hr prior to differentiation, or IFN- (500 U/ml, #130093; Miltenyi Biotec) during the entire time course of differentiation.
C3H10T1/2 cell differentiation
avidin-biotin-horseradish peroxidase complex. Labeling was detected with 2,3'-diaminobenzidine tetrahydrochloride (DAB) and examined using a light microscope.
The inflammation of adipose tissues were examined by staining the sections with the macrophage specific anti-F4/80 and Alexa Fluor 488-conjugated monkey anti-rat IgG (H+L). Cell nuclei were staining with To-Pro-3. Fluorescent images were taken on a Zeiss LSM laser scanning microscope.
Oil Red O staining
Differentiated cells were washed with PBS twice and fixed with 10% formalin for 1 hr. Cells were then washed with 60% isopropanol followed by staining with Oil Red O working solution for 30 min. Cells were finally washed with water four times, and images were scanned.
Statistical analysis
All statistical analyses were performed using Prism 8 (GraphPad Software, Inc). Data are presented as the mean ± standard deviation (SD). Two-tailed unpaired Student's t-tests were performed for comparison of two groups, and multiple comparisons were carried out by two-way analysis of variance (ANOVA) with Holm-Sidak post-hoc tests. A p-value <0.05 was considered statistically significant. The sample size was not determined by statistical methods, and no samples or animals were excluded from the analysis.
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